Podcast

Destigmatizing Urology: Dr. Amarasekera discusses sexual minorities in urology

Author(s):

Urology Times staff

“Gay people have had this history of feeling like the health care system and the structures that are supposed to protect them haven't protected them and kept them safe,” says Channa Amarasekera, MD.

In this episode of Destigmatizing Urology, Urology Times Assistant Editor Janelle Hart spoke with Channa Amarasekera, MD. He discusses the history surrounding sexual minorities in the health care system and what clinicians can do to create a more accepting and supportive environment for this patient population. Amarasekera is a professor of urology at Northwestern University Feinberg School of Medicine in Evanston, Illinois.

Related Videos
Eric Li, MD, answers a question during a Zoom video interview
Man talking with doctor | Image Credit: © RFBSIP - stock.adobe.com
Evan Panken, MD, answers a question during a video interview
Evan Panken, MD, answers a question during a video interview
Blur image of hospital interior | Image Credit: © jakkapan - stock.adobe.com
Ziho Lee, MD, answers a question during a Zoom video interview
Related Content
PREVENT trial: Transperineal biopsy lowers risk of infection vs transrectal biopsy
September 20th 2024

PREVENT trial: Transperineal biopsy lowers risk of infection vs transrectal biopsy

Hannah Clarke
No patients in the transperineal cohort experienced an infection, compared with 1.6% of patients in the transrectal cohort.
Former MLB player Dave Winfield shares lessons from baseball, philanthropy
November 15th 2024

Former MLB player Dave Winfield shares lessons from baseball, philanthropy

Urology Times staff
In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.
Experts develop prostate biopsy risk calculator for Black men
March 4th 2024

Experts develop prostate biopsy risk calculator for Black men

Hannah Clarke
"We looked at people who were in the intermediate-risk zone, and we found that our calculator did do a better job of helping some of those men avoid unnecessary biopsies," says Adam B. Murphy, MD, MBA, MSCI.
Key updates from the AUA/ASRM male infertility guideline amendment
September 23rd 2024

Key updates from the AUA/ASRM male infertility guideline amendment

Urology Times staff
In this episode, Robert E. Brannigan, MD, and Juan J. Andino, MD, MBA, discuss the recent amendment to the AUA/ASRM guideline on male infertility.
Diagram of genitourinary system
January 16th 2024

PSMA PET-CT Imaging: Impact on Real-World Diagnosis and Management of Prostate Cancer

Jaideep S. Sohi, MD
In this companion article, Jaideep S. Sohi, MD, shares insights on PSMA-PET imaging’s impact on real-world diagnosis and management of prostate cancer.
Drug extends survival in prostate cancer with genetic mutations
December 8th 2023

Drug extends survival in prostate cancer with genetic mutations

Northwestern Medicine
“Our analysis suggests that there is superior clinical benefit with olaparib versus control both in patients who had and had not received previous taxane treatment,” said Maha Hussain, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
© 2024 MJH Life Sciences

All rights reserved.